Healthcare provider profile · identity verified

Stephen Lee Shepherd, DO

Family Practice · LAKEWOOD, CO · NPI 1952697328

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	445	134
Lisinopril	Lisinopril	330	104
Levothyroxine Sodium	Levothyroxine Sodium	294	86
Tamsulosin Hcl	Tamsulosin Hcl	236	74
Oxycodone Hcl	Oxycodone Hcl	204	41
Simvastatin	Simvastatin	200	54
Metformin Hcl	Metformin Hcl	198	55
Losartan Potassium	Losartan Potassium	190	57
Amlodipine Besylate	Amlodipine Besylate	174	57
Rosuvastatin Calcium	Rosuvastatin Calcium	169	52
Gabapentin	Gabapentin	158	59
Omeprazole	Omeprazole	153	54
Albuterol Sulfate Hfa	Albuterol Sulfate	147	71
Metoprolol Tartrate	Metoprolol Tartrate	127	38
Pantoprazole Sodium	Pantoprazole Sodium	114	38
Pradaxa	Dabigatran Etexilate Mesylate	106	35
Glipizide	Glipizide	104	28
Atenolol	Atenolol	103	29
Meloxicam	Meloxicam	96	39
Furosemide	Furosemide	84	33
Hydrochlorothiazide	Hydrochlorothiazide	84	27
Trazodone Hcl	Trazodone Hcl	82	31
Pregabalin	Pregabalin	81	20
Duloxetine Hcl	Duloxetine Hcl	80	28
Metformin Hcl Er	Metformin Hcl	77	21
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	73	17
Tramadol Hcl	Tramadol Hcl	73	26
Mirtazapine	Mirtazapine	71	25
Jardiance	Empagliflozin	68	22
Alendronate Sodium	Alendronate Sodium	67	26
Tizanidine Hcl	Tizanidine Hcl	66	24
Metoprolol Succinate	Metoprolol Succinate	61	17
Allopurinol	Allopurinol	58	14
Fluticasone Propionate	Fluticasone Propionate	57	20
Sertraline Hcl	Sertraline Hcl	55	18
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	54	14
Finasteride	Finasteride	53	18
Spiriva Respimat	Tiotropium Bromide	52	22
Warfarin Sodium	Warfarin Sodium	52	15
Clopidogrel	Clopidogrel Bisulfate	51	15
Ozempic	Semaglutide	49	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	49	21
Carvedilol	Carvedilol	48	14
Prednisone	Prednisone	47	21
Solifenacin Succinate	Solifenacin Succinate	47	16
Triamcinolone Acetonide	Triamcinolone Acetonide	46	33
Famotidine	Famotidine	44	15
Humulin N	Insulin Nph Human Isophane	44	16
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	44	22
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	43	suppressed
Acyclovir	Acyclovir	41	16
Venlafaxine Hcl Er	Venlafaxine Hcl	41	11
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	38	11
Adacel Tdap	Diph,pertuss(Acell),tet Vac/Pf	36	36
Ezetimibe	Ezetimibe	36	suppressed
Humulin R	Insulin Regular, Human	35	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	35	34
Potassium Chloride	Potassium Chloride	34	12
Doxazosin Mesylate	Doxazosin Mesylate	33	11
Methocarbamol	Methocarbamol	32	suppressed
Ketoconazole	Ketoconazole	31	14
Arexvy	Rsvpref3 Antigen/As01e/Pf	30	30
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	30	24
Ondansetron Odt	Ondansetron	30	13
Donepezil Hcl	Donepezil Hcl	27	suppressed
Bupropion Xl	Bupropion Hcl	26	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	26	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	26	suppressed
Alvesco	Ciclesonide	25	suppressed
Azelastine Hcl	Azelastine Hcl	25	17
Lidocaine	Lidocaine	25	suppressed
Montelukast Sodium	Montelukast Sodium	24	suppressed
Lovastatin	Lovastatin	23	suppressed
Cefuroxime	Cefuroxime Axetil	22	19
Fluoxetine Hcl	Fluoxetine Hcl	22	11
Citalopram Hbr	Citalopram Hydrobromide	21	suppressed
Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	21	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	20	19
Propranolol Hcl	Propranolol Hcl	20	suppressed
Spironolactone	Spironolactone	20	suppressed
Insulin Syringe	Syringe And Needle,insulin,1ml	19	suppressed
Morphine Sulfate Er	Morphine Sulfate	18	suppressed
Trospium Chloride	Trospium Chloride	18	suppressed
Buprenorphine	Buprenorphine	17	suppressed
Buspirone Hcl	Buspirone Hcl	17	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	17	suppressed
Cephalexin	Cephalexin	16	suppressed
Digoxin	Digoxin	16	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	16	suppressed
Pravastatin Sodium	Pravastatin Sodium	16	suppressed
Cholestyramine	Cholestyramine (With Sugar)	15	suppressed
Eliquis	Apixaban	15	suppressed
Ropinirole Hcl	Ropinirole Hcl	15	suppressed
Baclofen	Baclofen	14	suppressed
Chlorthalidone	Chlorthalidone	14	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	14	12
Hydrocortisone	Hydrocortisone	14	suppressed
Ipratropium Bromide	Ipratropium Bromide	14	suppressed
Lorazepam	Lorazepam	14	12
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	14	suppressed
Carbamazepine	Carbamazepine	13	suppressed
Celecoxib	Celecoxib	13	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	13	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	13	suppressed
Azithromycin	Azithromycin	12	suppressed
Carbamazepine Er	Carbamazepine	12	suppressed
Clobetasol Propionate	Clobetasol Propionate	12	suppressed
Colchicine	Colchicine	12	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	12	suppressed
Testosterone	Testosterone	12	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	11	suppressed
Cinacalcet Hcl	Cinacalcet Hcl	11	suppressed
Dicloxacillin Sodium	Dicloxacillin Sodium	11	suppressed
Levetiracetam	Levetiracetam	11	suppressed
Memantine Hcl	Memantine Hcl	11	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error